Furthermore, it has previously been demonstrated that miR-34c suppressed cell growth in vitro and inhibited tumor growth in vivo by targeting MARCKS, thus suggesting that miR-34c was a novel tumor suppressor in osteosarcoma [43]. The gene discussed is MARCKS; the disease is osteosarcoma.